Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
John
Kerins
Managing Director, Healthcare
Spring Biopharma
Apr 15 - 17, 2025
|
Boston, MA
Boston, MA
Read more
about ImmunityBio - 2024/12/10
$100.0 Million
Image
ImmunityBio
Confidentially Marketed Follow-on Offering
Active Bookrunner
Biopharma Ski Summit
Feb 02 - 04, 2025
|
Park City, UT
Park City, UT
Read more
about enGene, Inc.
$60.1 Million
Image
enGene, Inc.
PIPE
Joint Placement Agent
Read more
about Capricor Therapeutics, Inc.
$75.0 Million
Image
Capricor Therapeutics, Inc.
Follow-on offering
Left Bookrunner
Read more
about Crinetics Pharmaceuticals, Inc. 2024/10/08
$500.0 Million
Image
Crinetics Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Scholar Rock Holding Corporation
$300.0 Million
Image
Scholar Rock Holding Corporation
Follow-On Offering
Active Bookrunner
Read more
about CAMP4 - 2024/10/10
$75.0 Million
Image
CAMP4
Initial Public Offering
Active Bookrunner
Read more
about Upstream Bio, Inc. 2024/10/10
$297.5 Million
Image
Upstream Bio, Inc.
Initial Public Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 7
Next page
››
Subscribe to Biopharma